A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
- 2013-02-23
- RCT · n = 32
- Complementary therapies in medicine 21(3)
- Samantha Coulson
- Amanda Rao
- Shoshannah L Beck
- Elizabeth Steels
- Helen Gramotnev
- Luis Vitetta
- PubMed: 23642948
- DOI: 10.1016/j.ctim.2013.01.007
- High evidence
- Clinical
The night-time urinary frequency was also significantly reduced in the active group (2.9-1.8, 39.3% compared to placebo (2.8-2.6 times, 7%) (p < 0.004).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes